Table 1: Reports of cholangitis after heobilia.
References |
Age |
Sex |
Primary disease |
Antiplatelet or anticoagulant medication |
Cause of hemobilia |
Modality to detect the source of hemobilia |
Intervention for hemostasis |
Transfusion |
Intervention for cholangitis |
Recurrence |
Death due to hemobilia or cholangitis |
Hashioka |
54 |
F |
Hereditary hemorrhagec telangiectasia |
NS |
Hereditary hemorrhagec telangiectasia |
CT |
None |
NS |
ERCP, PS |
yes |
Death due to primary disease |
Yilmaz |
75 |
F |
Chronic hepatitis B |
no |
Percutaneous liver biopsy |
US |
TAE with coil |
yes |
ERCP, EST, PS |
no |
Alive |
Miyamoto |
72 |
M |
PSC, cholangiocarcinoma |
NS |
Hepatic artery aneurysm(due to PS) |
CE-CT |
TAE with coil |
NS |
ERC, EST, SEMS |
no |
Death due toprimary disease |
Galambo |
49 |
M |
Colorectal cancer |
NS |
PTBD |
angiography |
Trans biliary coil embolization |
NS |
IEBD |
no |
Death due toprimary disease |
Nakai |
78 |
F |
Cholangiocarcinoma |
NS |
Tumor involvement to orifice of cystic duct |
ERC |
None |
NS |
EUS-HGS |
no |
Alive |
Gollol-Raju |
61 |
M |
HCC |
yes |
Tumor |
CTA |
ERCP MS |
NS |
ERCP, EST, MS |
no |
Alive |
Yamauchi |
78 |
F |
Benign biliary stenosis |
no |
PS |
CE-CT |
TAE with coil |
NS |
ERCP, PS |
no |
Alive |
Ogura |
89 |
F |
HCC |
NS |
Tumor |
CT |
ERCP MS(fully covered SEMS) |
NS |
ERCP MS (fully covered SEMS) |
no |
Death due toprimary disease |
An |
75 |
M |
Hepatic artery aneurysm |
no |
Hepatic artery aneurysm |
CT |
Coil embolization and trans biliary coil embolization |
NS |
PTBD |
no |
Alive |
Ahmad |
25 |
M |
Type I Giant Choledochal Cyst |
no |
Arteriocholedochal fistulas |
CE-CT |
Surgery(whipple's pancreatoduodenectomy) |
yes |
- |
no |
Alive |
Lynn |
65 |
M |
Cholangitis |
NS |
PTBD |
ERC |
Surgery(laparoscopic cholecystectomy and CBD exploration) |
NS |
ERC, PS (failed) |
no |
Alive |
F: Female; M: Male; NS: Not Shown; PSC: Primary Sclerosing Cholangitis; HCC: Hepatocellular Carcinoma; PTBD: Perctaneous Transhepatic Biliary Drainage; PS: Plastic Stent; CT: Computed Tomography; US: Ultrasonography; ERC: Endoscopic Retrograde Cholangiography; CTA: Computed Tomography Angiography; CE-CT: Contrast-Enhanced Computed Tomography;TAE: Transarterial Embolization; ERCP: Endscopic Retrograde Cholangiopancreatography; MS: Metalic Stent; CBD: Common Bile Duct; EST: Endoscopic Sphincterotomy; SEMS: Self-Expandable Metal Stent; IEBD: Internal-External Biliary Drainage; EUS-HGS: Endoscopic Ultrasound-Hepaticogastrostomy. |